Pelish Henry E., Chief Scientific Officer of Nuvalent, Inc. ($NUVL), sold shares on the open market twenty-one times over the last 365 days, totaling about $4.9 million. His most recent sale occurred on January 6, 2026. These sales rank 1,974th among 11,678 individual insiders, below the average sale amount of $8.6 million and average of 6.4 transactions. He made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 12, 2026 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Class A Common Stock | 8456 | $18.93 | 91,844.0000 | 72,143,466 | 10.14% | 0.01% |
| March 12, 2026 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | S | Class A Common Stock | 306 | $99.12 | 70,708.0000 | 72,143,466 | 0.43% | 0.00% |
| March 12, 2026 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | S | Class A Common Stock | 5505 | $98.44 | 71,014.0000 | 72,143,466 | 7.19% | 0.01% |
| March 12, 2026 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | S | Class A Common Stock | 24189 | $97.79 | 76,519.0000 | 72,143,466 | 24.02% | 0.03% |
| March 12, 2026 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Class A Common Stock | 2985 | $72.35 | 100,708.0000 | 72,143,466 | 3.05% | 0.00% |
| March 12, 2026 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Class A Common Stock | 4125 | $29.33 | 97,723.0000 | 72,143,466 | 4.41% | 0.01% |
| March 12, 2026 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Class A Common Stock | 1754 | $27.85 | 93,598.0000 | 72,143,466 | 1.91% | 0.00% |
| March 13, 2026 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | S | Class A Common Stock | 804 | $97.89 | 69,904.0000 | 72,143,466 | 1.14% | 0.00% |
| March 13, 2026 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | S | Class A Common Stock | 2597 | $98.83 | 67,307.0000 | 72,143,466 | 3.72% | 0.00% |
| March 13, 2026 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | S | Class A Common Stock | 1703 | $99.71 | 65,604.0000 | 72,143,466 | 2.53% | 0.00% |
| March 12, 2026 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 8456 | $0.00 | 2,113.0000 | 72,143,466 | 80.01% | 0.01% |
| March 12, 2026 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 1754 | $0.00 | 11,402.0000 | 72,143,466 | 13.33% | 0.00% |
| March 12, 2026 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 4125 | $0.00 | 9,900.0000 | 72,143,466 | 29.41% | 0.01% |
| March 12, 2026 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 2985 | $0.00 | 21,073.0000 | 72,143,466 | 12.41% | 0.00% |
| Jan. 7, 2026 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | A | Class A Common Stock | 17500 | $0.00 | 83,388.0000 | 72,143,466 | 26.56% | 0.02% |
| Jan. 7, 2026 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | A | Stock Option (Right to Buy) | 17500 | $0.00 | 17,500.0000 | 72,143,466 | 9999.99% | 0.02% |
| Jan. 6, 2026 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | S | Class A Common Stock | 189 | $98.40 | 65,888.0000 | 72,143,466 | 0.29% | 0.00% |
| Jan. 6, 2026 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | S | Class A Common Stock | 1369 | $97.33 | 66,077.0000 | 72,143,466 | 2.03% | 0.00% |
| Jan. 6, 2026 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | S | Class A Common Stock | 1106 | $96.75 | 67,446.0000 | 72,143,466 | 1.61% | 0.00% |
| Jan. 5, 2026 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | S | Class A Common Stock | 186 | $98.52 | 68,552.0000 | 72,143,466 | 0.27% | 0.00% |
| Jan. 5, 2026 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | S | Class A Common Stock | 1137 | $97.96 | 68,738.0000 | 72,143,466 | 1.63% | 0.00% |
| Jan. 5, 2026 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | S | Class A Common Stock | 660 | $96.85 | 69,875.0000 | 72,143,466 | 0.94% | 0.00% |
| Jan. 5, 2026 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | S | Class A Common Stock | 513 | $96.06 | 70,535.0000 | 72,143,466 | 0.72% | 0.00% |
| Dec. 22, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 5085 | $0.00 | 0.0000 | 72,143,466 | 100.00% | 0.01% |
| Dec. 22, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Class A Common Stock | 5085 | $1.08 | 71,048.0000 | 72,143,466 | 7.71% | 0.01% |
| Oct. 15, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 3668 | $0.00 | 10,569.0000 | 72,143,466 | 25.76% | 0.01% |
| Oct. 15, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Class A Common Stock | 3668 | $18.93 | 69,631.0000 | 72,143,466 | 5.56% | 0.01% |
| Oct. 15, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 3042 | $0.00 | 24,058.0000 | 72,143,466 | 11.23% | 0.00% |
| Oct. 15, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Class A Common Stock | 3042 | $72.35 | 80,168.0000 | 72,143,466 | 3.94% | 0.00% |
| Oct. 15, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | S | Class A Common Stock | 14205 | $90.04 | 65,963.0000 | 72,143,466 | 17.72% | 0.02% |
| Oct. 15, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Class A Common Stock | 7495 | $27.85 | 77,126.0000 | 72,143,466 | 10.76% | 0.01% |
| Oct. 15, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 7495 | $0.00 | 13,156.0000 | 72,143,466 | 36.29% | 0.01% |
| Oct. 13, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Class A Common Stock | 1800 | $72.35 | 73,600.0000 | 72,143,466 | 2.51% | 0.00% |
| Oct. 13, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Class A Common Stock | 4168 | $27.85 | 71,800.0000 | 72,143,466 | 6.16% | 0.01% |
| Oct. 13, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Class A Common Stock | 1669 | $18.93 | 67,632.0000 | 72,143,466 | 2.53% | 0.00% |
| Oct. 14, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 731 | $0.00 | 14,237.0000 | 72,143,466 | 4.88% | 0.00% |
| Oct. 13, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 1800 | $0.00 | 27,100.0000 | 72,143,466 | 6.23% | 0.00% |
| Oct. 13, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 4168 | $0.00 | 21,528.0000 | 72,143,466 | 16.22% | 0.01% |
| Oct. 13, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 1669 | $0.00 | 14,968.0000 | 72,143,466 | 10.03% | 0.00% |
| Oct. 14, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | S | Class A Common Stock | 400 | $87.39 | 65,963.0000 | 72,143,466 | 0.60% | 0.00% |
| Oct. 14, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | S | Class A Common Stock | 866 | $86.11 | 66,363.0000 | 72,143,466 | 1.29% | 0.00% |
| Oct. 14, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | S | Class A Common Stock | 1167 | $84.98 | 67,229.0000 | 72,143,466 | 1.71% | 0.00% |
| Oct. 14, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Class A Common Stock | 825 | $29.33 | 68,396.0000 | 72,143,466 | 1.22% | 0.00% |
| Oct. 14, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Class A Common Stock | 877 | $27.85 | 67,571.0000 | 72,143,466 | 1.31% | 0.00% |
| Oct. 14, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Class A Common Stock | 731 | $18.93 | 66,694.0000 | 72,143,466 | 1.11% | 0.00% |
| Oct. 13, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | S | Class A Common Stock | 7637 | $89.81 | 65,963.0000 | 72,143,466 | 10.38% | 0.01% |
| Oct. 14, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 825 | $0.00 | 14,025.0000 | 72,143,466 | 5.56% | 0.00% |
| Oct. 14, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 877 | $0.00 | 20,651.0000 | 72,143,466 | 4.07% | 0.00% |
| Sept. 10, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Class A Common Stock | 877 | $27.85 | 67,571.0000 | 66,408,807 | 1.31% | 0.00% |
| Sept. 10, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 731 | $0.00 | 16,637.0000 | 66,408,807 | 4.21% | 0.00% |
| Sept. 10, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 877 | $0.00 | 25,696.0000 | 66,408,807 | 3.30% | 0.00% |
| Sept. 10, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 2117 | $0.00 | 14,850.0000 | 66,408,807 | 12.48% | 0.00% |
| Sept. 10, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Class A Common Stock | 731 | $18.93 | 66,694.0000 | 66,408,807 | 1.11% | 0.00% |
| Sept. 10, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Class A Common Stock | 2117 | $29.33 | 69,688.0000 | 66,408,807 | 3.13% | 0.00% |
| Sept. 10, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | S | Class A Common Stock | 3725 | $78.83 | 65,963.0000 | 66,408,807 | 5.35% | 0.01% |
| Aug. 29, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Class A Common Stock | 3000 | $1.08 | 65,963.0000 | 66,408,807 | 4.76% | 0.00% |
| Aug. 29, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 2007 | $0.00 | 0.0000 | 66,408,807 | 100.00% | 0.00% |
| Aug. 29, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 3000 | $0.00 | 5,085.0000 | 66,408,807 | 37.11% | 0.00% |
| Aug. 29, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Class A Common Stock | 2007 | $0.87 | 62,963.0000 | 66,408,807 | 3.29% | 0.00% |
| Aug. 7, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Class A Common Stock | 731 | $18.93 | 61,687.0000 | 66,408,807 | 1.20% | 0.00% |
| Aug. 7, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Class A Common Stock | 877 | $27.85 | 62,564.0000 | 66,408,807 | 1.42% | 0.00% |
| Aug. 7, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Class A Common Stock | 3892 | $29.33 | 66,456.0000 | 66,408,807 | 6.22% | 0.01% |
| Aug. 7, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | S | Class A Common Stock | 5500 | $74.85 | 60,956.0000 | 66,408,807 | 8.28% | 0.01% |
| Aug. 7, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 731 | $0.00 | 17,368.0000 | 66,408,807 | 4.04% | 0.00% |
| Aug. 7, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 877 | $0.00 | 26,573.0000 | 66,408,807 | 3.19% | 0.00% |
| Aug. 7, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 3892 | $0.00 | 16,967.0000 | 66,408,807 | 18.66% | 0.01% |
| July 10, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 4440 | $0.00 | 20,859.0000 | 66,408,807 | 17.55% | 0.01% |
| July 9, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | S | Class A Common Stock | 1945 | $81.08 | 61,156.0000 | 66,408,807 | 3.08% | 0.00% |
| July 9, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | S | Class A Common Stock | 200 | $81.90 | 60,956.0000 | 66,408,807 | 0.33% | 0.00% |
| July 10, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Class A Common Stock | 182 | $18.93 | 61,138.0000 | 66,408,807 | 0.30% | 0.00% |
| July 10, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Class A Common Stock | 878 | $27.85 | 62,016.0000 | 66,408,807 | 1.44% | 0.00% |
| July 10, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Class A Common Stock | 4440 | $29.33 | 66,456.0000 | 66,408,807 | 7.16% | 0.01% |
| July 10, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | S | Class A Common Stock | 5260 | $79.94 | 61,196.0000 | 66,408,807 | 7.92% | 0.01% |
| July 10, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | S | Class A Common Stock | 240 | $80.92 | 60,956.0000 | 66,408,807 | 0.39% | 0.00% |
| July 10, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 182 | $0.00 | 18,099.0000 | 66,408,807 | 1.00% | 0.00% |
| July 10, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 878 | $0.00 | 27,450.0000 | 66,408,807 | 3.10% | 0.00% |
| June 27, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 347 | $0.00 | 28,328.0000 | 66,408,807 | 1.21% | 0.00% |
| June 25, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Class A Common Stock | 3677 | $27.85 | 66,778.0000 | 66,408,807 | 5.83% | 0.01% |
| June 25, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Class A Common Stock | 4953 | $29.33 | 71,731.0000 | 66,408,807 | 7.42% | 0.01% |
| June 25, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | S | Class A Common Stock | 8630 | $79.87 | 63,101.0000 | 66,408,807 | 12.03% | 0.01% |
| June 27, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Class A Common Stock | 347 | $27.85 | 63,448.0000 | 66,408,807 | 0.55% | 0.00% |
| June 27, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Class A Common Stock | 1823 | $29.33 | 65,271.0000 | 66,408,807 | 2.87% | 0.00% |
| June 27, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | S | Class A Common Stock | 2170 | $79.92 | 63,101.0000 | 66,408,807 | 3.32% | 0.00% |
| June 25, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 3677 | $0.00 | 28,675.0000 | 66,408,807 | 11.37% | 0.01% |
| June 25, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 4953 | $0.00 | 27,122.0000 | 66,408,807 | 15.44% | 0.01% |
| June 27, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 1823 | $0.00 | 25,299.0000 | 66,408,807 | 6.72% | 0.00% |
| June 6, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 100 | $0.00 | 32,075.0000 | 66,408,807 | 0.31% | 0.00% |
| June 6, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 100 | $0.00 | 32,352.0000 | 66,408,807 | 0.31% | 0.00% |
| June 6, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | S | Class A Common Stock | 200 | $79.82 | 63,101.0000 | 66,408,807 | 0.32% | 0.00% |
| June 6, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Class A Common Stock | 100 | $29.33 | 63,301.0000 | 66,408,807 | 0.16% | 0.00% |
| June 6, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Class A Common Stock | 100 | $27.85 | 63,201.0000 | 66,408,807 | 0.16% | 0.00% |
| Jan. 31, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Class A Common Stock | 3120 | $0.87 | 63,101.0000 | 66,408,807 | 5.20% | 0.00% |
| Jan. 31, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 3120 | $0.00 | 2,007.0000 | 66,408,807 | 60.85% | 0.00% |
| Jan. 6, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | S | Class A Common Stock | 712 | $78.28 | 61,752.0000 | 66,408,807 | 1.14% | 0.00% |
| Jan. 6, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | S | Class A Common Stock | 428 | $79.33 | 61,324.0000 | 66,408,807 | 0.69% | 0.00% |
| Jan. 6, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | S | Class A Common Stock | 1343 | $80.54 | 59,981.0000 | 66,408,807 | 2.19% | 0.00% |
| Jan. 6, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | A | Class A Common Stock | 18750 | $0.00 | 62,464.0000 | 66,408,807 | 42.89% | 0.03% |
| Jan. 6, 2025 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | A | Stock Option (Right to Buy) | 37500 | $0.00 | 37,500.0000 | 66,408,807 | 9999.99% | 0.06% |
| Dec. 16, 2024 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 5914 | $0.00 | 0.0000 | 65,678,693 | 100.00% | 0.01% |
| Dec. 16, 2024 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Class A Common Stock | 5914 | $0.65 | 39,214.0000 | 65,678,693 | 17.76% | 0.01% |
| Dec. 16, 2024 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Class A Common Stock | 4500 | $0.87 | 43,714.0000 | 65,678,693 | 11.48% | 0.01% |
| Dec. 16, 2024 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 4500 | $0.00 | 5,127.0000 | 65,678,693 | 46.74% | 0.01% |
| Sept. 16, 2024 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | S | Class A Common Stock | 100 | $102.80 | 33,300.0000 | 58,223,339 | 0.30% | 0.00% |
| Sept. 16, 2024 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | S | Class A Common Stock | 1966 | $93.25 | 64,129.0000 | 58,223,339 | 2.97% | 0.00% |
| Sept. 16, 2024 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | S | Class A Common Stock | 3754 | $94.80 | 60,375.0000 | 58,223,339 | 5.85% | 0.01% |
| Sept. 16, 2024 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | S | Class A Common Stock | 1548 | $95.36 | 58,827.0000 | 58,223,339 | 2.56% | 0.00% |
| Sept. 16, 2024 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | S | Class A Common Stock | 4105 | $96.61 | 54,722.0000 | 58,223,339 | 6.98% | 0.01% |
| Sept. 16, 2024 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | S | Class A Common Stock | 3197 | $97.54 | 51,525.0000 | 58,223,339 | 5.84% | 0.01% |
| Sept. 16, 2024 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | S | Class A Common Stock | 706 | $98.22 | 50,819.0000 | 58,223,339 | 1.37% | 0.00% |
| Sept. 16, 2024 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | S | Class A Common Stock | 4094 | $100.25 | 46,725.0000 | 58,223,339 | 8.06% | 0.01% |
| Sept. 16, 2024 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | S | Class A Common Stock | 5513 | $101.18 | 41,212.0000 | 58,223,339 | 11.80% | 0.01% |
| Sept. 16, 2024 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | S | Class A Common Stock | 7812 | $102.54 | 33,400.0000 | 58,223,339 | 18.96% | 0.01% |
| Aug. 23, 2024 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | S | Class A Common Stock | 10500 | $85.08 | 66,095.0000 | 58,223,339 | 13.71% | 0.02% |
| July 9, 2024 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | A | Class A Common Stock | 13100 | $0.00 | 76,595.0000 | 58,223,339 | 20.63% | 0.02% |
| July 9, 2024 | Nuvalent, Inc. | $NUVL | Pelish Henry E. | Chief Scientific Officer | A | Stock Option (Right to Buy) | 18600 | $0.00 | 18,600.0000 | 58,223,339 | 9999.99% | 0.03% |